1- AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project. Qual Saf Health Care. 2003;12 :18 –23
2- NIH Consensus Development Panel on Osteoporosis. JAMA 2001; 285: 785-95
3- Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009; 301:513-21
4- Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15: 721-739
5- Dargent-Molina P, Favier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996; 348:145-9
6- Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX® and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19: 385–97
8- Bone HG, Hosking DH, Devogelaer JP, et al. Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 2004; 350: 1189-1199
9- Siminoski K, Jiang G, Adachi JD, Hanley et al. The accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int 2005; 16:403–410
10- Briot K, Legrand E, Pouchain D, Monnier S, Roux C. Accuracy of patient-reported height loss and risk factors for height loss among postmenopausal women. CMAJ. 2010; 6; 182:558-62
11- Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res. 2003;18(6):1051-6
12- Schilcher J, Michaëlsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011;364: 1728-37
13- Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C.The impact of compliance with osteoporosis therapy on fracture rates in actual practice.Osteoporos Int. 2004 15(12):1003-8
14- Sung JC, Nichol MB, Venturini F, Bailey KL, McCombs JS, Cody M. Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care. 1998 ; 4(10):1421-30.
Mise au point
Prise en charge de la goutte en 2025
Mise au point
Le prurit
Mise au point
Les infiltrations en médecine générale
Mise au point
Diagnostic de la maladie d’Alzheimer en 2025